The solid-liquid solubility of the thermodynamically stable form I of the drug risperidone has been determined by a gravimetric method in nine pure organic solvents in the temperature range 278.15-323.15 K. The melting temperature and associated enthalpy of fusion of risperidone form I has been determined by differential scanning calorimetry (DSC) to be 442.38 K and 43.94 kJ mol -1 , respectively. The heat capacity of the solid form I and the melt have been determined over a range of temperatures by temperature-modulated DSC, and extrapolated data has been used to calculate the Gibbs energy, enthalpy and entropy of fusion from ambient temperature up to the melting point. The ideal solubility within a Raoult's law framework is obtained from the Gibbs energy of fusion, and the solution activity coefficient at equilibrium in the nine solvents quantified. Solutions in all solvents exhibit positive deviation from Raoult's law, with the highest solubility (closest to ideality) in toluene, an aprotic apolar solvent. The solubility curves plotted in a van't Hoff graph show non-linear behaviour and are well-approximated by a second order polynomial.
Introduction
The solid-liquid solubility of an organic pharmaceutical compound is a very important property which affects its entire lifespan, from synthesis through isolation and formulation down to its bioavailability within the human body. Having access to accurate solubility data in a relevant selection of solvents is crucial for the control and optimisation of different steps of the manufacturing process. It is of particular importance in crystallisation processes, where knowledge of the solubility is needed in order to be able to control the supersaturation, particle size, desired polymorphic form and yield.
Risperidone, CAS number 106266-06-2, is an atypical benzisoxazole neuroleptic drug mainly used to treat schizophrenia, manic states associated with bipolar disorder, and schizoaffective disorder. Its main pharmacological activity is the blocking of the serotonin type 2 (5HT2) receptor and dopamine type 2 (D2) antagonism [1] . The molecular formula of risperidone is C23H27FN4O2 (M.W. 410.485 g mol -1 ) and its molecular structure is shown in Fig. 1 . There are two reported polymorphs with crystal structures available in the Cambridge Structural Database (CSD) [2, 3] . However, very limited data is available on the solid-liquid solubility of risperidone.
In this work, we report the solubility over the temperature range 278.15-323.15 K in nine pure organic solvents of the stable polymorph of risperidone, sometimes referred to as form A but henceforth termed form I in accordance with McCrone's generally accepted standard naming conventions [4] . The melting properties and the heat capacity of the pure compound in the solid state and as a melt have been determined. Based on the thermal analysis, the thermodynamics of fusion of the solid are investigated, and the ideal solubility is estimated as a function of temperature, allowing activity coefficients in the nine solvents to be calculated. Table 1 lists the chemicals used, together with the source and stated purity. All chemicals were used as received without further purification. 
Experimental work

Materials
Solubility
Solubility was determined using a gravimetric method described previously [5] . Temperature was controlled using a Grant S26 water bath equipped with a GR150 control unit (specified stability of ±0.005 K) and a Grant C2G cooling unit. A temperature uniformity of ±0.01 K was achieved by providing additional agitation to the bath using a submersible pump. A 60-point submersible magnetic stirring plate (2Mag) provided agitation at 600 rpm. Solutions were equilibrated for 24 h at each temperature in 20 ml glass vials (70 x 25 mm), each containing a PTFE coated magnetic stirring bar (13 x 3 mm) and sealed with a screw cap with a PTFE coated insert. Equilibrium was always approached from below the desired temperature point (i.e. via dissolution). After the equilibration period stirring was switched off for 1 h to allow excess solids to settle in the vials. A sample of the excess solid material in each vial was collected. Samples of the clear solution (approx. 4 ml) were extracted in triplicate using pre-heated syringes and filtered through 0.2 μm solvent-compatible (PTFE or Nylon) filters into pre-weighed glass vials (50 x 25 mm). The filtered solutions were then immediately capped and weighed. The caps were then removed and stored, allowing the solvent to evaporate at room temperature for a period of at least 3 days in a ventilated fume hood. When vials were visibly solvent-free they were placed in an oven at 323 K for 8 h to ensure dryness before being placed in a desiccator overnight to return to ambient temperature. The dry vials were then weighed together with the caps to determine the amount of risperidone dissolved in the solution. All weights were determined with an Ohaus Explorer balance accurate to ±0.0001 g. In each of the nine solvents listed in section 2.1, solubility was measured in the temperature range 278.15-323.15 K with steps of 5 K. X-ray powder diffraction (XRPD, Philips PANalytical X'Pert MPD Pro with a PW3064 sample spinner) was used to analyse the sampled excess solid material. Scans in the 2θ-range 5-35 ° allowed identification of the polymorph by comparison with the theoretical patterns generated from the structures published in the CSD.
Thermal analysis
The melting temperature, Tm, and the associated enthalpy of fusion, ΔfusH, of risperidone form I were determined by differential scanning calorimetry (DSC) using a PerkinElmer Pyris 1, in six repeat runs using a constant heating rate of 1 K min -1 from 293-453 K. Samples were prepared in hermetically sealed aluminium pans with the furnace purged with nitrogen gas at a rate of 50 ml min -1 .
Heat capacity measurements were conducted using a TA Instruments MDSC 2920 operated in modulated mode using non-hermetic aluminium sample pans. A modulation period of 100 s and amplitude of 1 K were used, with an underlying constant heating rate of 3 K min -1 . Each powder sample (4-9 mg) was distributed evenly in the pan and covered with a lid without crimping, and the furnace was purged with nitrogen gas at a rate of 50 ml min -1 . The heat capacity of the solid was measured by heating the material once to just below its melting point. The heat capacity of the melt was obtained in dual scans of each sample, by heating the solid material past the melting point to 458 K, then cooling the melt to 428 K followed by heating the melt to 458 K (first scan), then cooling the melt to 423 K followed by heating the melt to 453 K (second scan), discarding scans where the melt recrystallized during cooling. Calibration of both calorimeters was carried out according to standard procedure against the melting properties of indium. Heat capacity calibration was made using sapphire and a linear calibration correction function based on three repeat scans from 273-473 K. Differences in mass between sample pan and reference pan were within ±0.10 mg.
Thermogravimetric analysis (TGA) was carried out using a TA Instruments SDT Q600, conducted under both air and nitrogen gas atmosphere, respectively, using a flow rate of 100 ml min -1 . Samples were prepared in open alumina pans and heated at a rate of 10 K min -1 from 298-773 K.
Results
Thermal analysis
A representative DSC thermogram of the melting of form I is shown in Fig. 2a . The average values over six DSC scans of the melting temperature (Tm) and the enthalpy of fusion at the melting temperature (Δ fus H) of form I are given in Table 2 . The value of T m determined in this work as the mean extrapolated onset temperature (442.4 K) is slightly less than the value reported by Silva et al. [6] (443.6 K), and slightly higher than those reported by Germann et al. [1] (441.8 K) and Shah et al. [7] (439.9 K), although it should be noted that these studies all used risperidone of unspecified or lower purity, higher heating rates (5-10 K min -1 ), and give no estimate on the confidence of their data. The value of the melting enthalpy determined here (43.94 kJ mol -1 ) is slightly lower than the value reported by Silva et al. [6] (45.28 kJ mol -1 ) . No evidence of solid phase transformation prior to melting was observed. Examination of the DSC pan contents after heating to 10 K past Tm followed by recrystallisation during cooling to room temperature indicates a colour change from white to yellow, which could suggest partial decomposition. This was investigated using TGA, and the results are shown in Fig. 2 b. Detectable mass loss began to occur after approx. 490 K in air, with 0.01% mass loss reached at 492 K. Under nitrogen atmosphere, mass loss was not detected until approx. 500 K, with 0.01% mass loss attained at 504 K. The absence of volatilisation until 490 K lends confidence to the results of the calorimetric analyses, which were conducted well below the lowest temperature of detectable sublimation and/or decomposition. Table 3 , and experimental heat capacity data is provided as supplementary data (table A.1). 
Solubility
The solubility of risperidone form I between 278.15-323.15 K in the nine evaluated solvents is given in Table 4 as mole fractions, and shown in Fig. 4 as g risperidone per kg solvent. Values are averages over three samples from each solution. The main reason for the chosen upper limit in temperature is that data was chiefly intended to support a separate study of primary nucleation conducted in this temperature region (to be published separately). In addition, it was observed that solutions equilibrated for extended periods at higher temperatures would gradually take on a yellow hue, suggesting degradation. No colour changes were observed in the chosen temperature range in any of the investigated solvents. The mole fraction solubility data in each solvent was correlated by Eq. (2):
where T is the temperature in K and A, B and C are regression coefficients valid within the temperature range 278-323 K. The coefficients of Eq. (2) obtained for each solvent by least squares fitting to the data in Table 4 are displayed in Table 5 together with coefficients of determination. Examples of XRPD patterns of the excess solids in the vials of the solubility experiments are presented in Fig. 5 . In all solutions, the solid material was verified to be form I. All experimental peaks match those in the theoretical pattern generated from the known structure of risperidone form I [2] (refcode WASTEP). The theoretical pattern of form II [3] (refcode WASTEP01) contains a dominant peak at 21.78 ° and a distinctive region around 17-18 ° distinguishing it from form I, both of which are completely absent from all XRPD patterns collected. 
Analysis and discussion
The mole fraction solubility of a solid compound in a solvent at a temperature T is given by the activity of the solute in the saturated solution, aeq -which is equal to that of the pure solid phase, a s -and the activity coefficient at that temperature and concentration, γeq:
In the customary Raoult's law definition, the activity of the solid is defined in relation to the pure supercooled melt at the same temperature, so that a solution is denoted as ideal when the activity coefficient equals unity. Within this definition, the activity of the solid is related to the Gibbs energy of fusion, according to Eq's (4-7) [8, 9] : If the melting temperature and the associated enthalpy of melting are known, and the heat capacity difference between the solid and the supercooled liquid can be estimated with reasonable confidence, the Gibbs energy of fusion and its enthalpic and entropic components, and thence the activity of the pure solid, can be computed as functions of temperature.
Extrapolating the linear regression models for the heat capacities of form I and the melt, Eq. (1), and subtracting the solid from the liquid gives a linearly decaying function for the heat capacity difference with increasing T, Eq. (8), with the coefficients q = 158.09 J K -1 mol -1 and r = 0.5214 J K -2 mol -1 . The extrapolated function is shown in Fig. 3 . At Tm, the heat capacity difference is equal to q, viz. 158.1 J K -1 mol -1 , increasing to 243.7 J K -1 mol -1 at 278 K.
In Fig. 6 , the resulting Gibbs energy of fusion of form I is shown together with its component terms. The enthalpy of fusion at room temperature is only about half the value at T m , showing the importance of the heat capacity term in Eq. (5). However, because of enthalpy-entropy compensation, ΔfusG only changes by 10 kJ mol -1 from ambient temperature to the melting point. vs. absolute temperature for risperidone form I estimated using calorimetric melting data and heat capacities extrapolated using Eq. (8).
For an ideal solution, ln γeq equals zero and the solubility equals the activity of the pure solid. It has been suggested [10] that, for the purpose of estimating the activity of the solid, ΔCp could be approximated by the entropy change upon melting. In the case of risperidone, ΔfusS (T m ) as calculated from experimental melting data is 99 J K -1 mol -1 , which is quite far below the corresponding heat capacity value obtained experimentally and clearly would lead to an underestimation of the influence of ΔCp on the thermodynamics of fusion and the activity of the solid.
In Fig. 7 , the activity of solid risperidone, calculated using Eq. (7), is shown as a solid black line. Fig. 7 also shows the solubility of risperidone in five representative solvents as ln xeq vs. T -1 with lines representing fits of Eq. (2). The curves of the remaining four solvents behave in a similar way, and are located within the boundary of the five that are shown, but are omitted for clarity. Fig. 7 . ln xeq of form I in five pure solvents plotted against T -1 , shown together with fits of Eq. (2). Also shown is the ideal solubility calculated using Eq. (7) together with calorimetric data.
The solubility curves trend towards the ideal solubility with increasing temperature, as they are expected to. In most reported solubility data van't Hoff plots are shown as straight lines. However, as given by Eq. (7) van't Hoff plots are inherently non-linear, even for ideal solutions, and this is indeed the general appearance of the curves in Fig. 7 , with the possible exception of cumene. A number of regression equations have been proposed for temperature correlation of solubility data, many of which were evaluated by Nordström and Rasmuson [11] . For risperidone, all of these provide good fits to the experimental solubility data in terms of average coefficients of determination, which exceeds 0.97 for all models including a linear equation in T -1 . However, Fig. 8 clearly shows that a plot of the average residuals in ln xeq vs. T are not randomly distributed, which reveals a systematic deviation between the straight line and the experimental data, whereas the residuals are much better distributed for the second-order polynomial given by Eq. (2). At room temperature the mole fraction solubility decreases in the order: toluene > methanol > 1 butanol > 1-propanol > cumene > ethyl acetate > ethanol > acetone > 2-propanol. In mole fraction terms, the solubility of risperidone form I is quite low in all the solvent systems evaluated in this study, with the highest value measured being 0.038 in toluene at 323 K.
Comparison with the ideal solubility shows that an important reason for the low mole fraction solubility is the low activity of the solid phase, which in turn is related to the fact that the experimental temperature range is more than 100 K below Tm. However, it should be noted that the molecular mass of risperidone is considerably higher than those of the evaluated solvents, and consequently the solubility on mass basis, shown in Fig. 4 , is fairly reasonable. Fig. 9 shows the activity coefficient in all nine solvents as a function of T, obtained by combining Eq. (3) and Eq. (7) and inserting experimental solubility and calorimetric data. In all the solvents at all temperatures the activity coefficient is clearly above unity, reflecting a considerable positive deviation from Raoult's law. At 278 K, the activity coefficients range from 4 (in toluene) to 42 (in 2-propanol). The activity coefficient in all solvents decrease monotonically and approach unity with increasing T, as the solution approaches ideality at Tm. Fig. 9 . γeq of form I in nine pure solvents plotted against T, shown together with fits based on Eq. (2), Eq. (3) and Eq. (7). Fig. 10 shows the electrostatic potential, calculated at the HF/6-311+G(d) level of theory using Gaussian 03w, mapped onto an electron density isosurface surrounding a risperidone molecule with the geometry corresponding to the form I crystal structure. The hydrocarbon parts of the various ring structures (benzyl, piperidine, pyrimidine) provide significant nonpolar regions, while the presence of oxygen, nitrogen, and fluorine creates electronegative areas suitable for hydrogen bond acceptance, most prominent at the carbonyl oxygen. However, notably, risperidone has no significant hydrogen bond donation capability. No simple correlation was found between the solubility and various solvent properties relating to polarity, e.g. dielectric constant or Reichardt's polarity parameter [12] . However, the process of solvation depends in a complex way on a multitude of other molecular properties of the solvent and the solute, such as the relative sizes of solute and solvent molecules, their polarisability, and their mutual ability to form strong and efficient interacting aggregates. This complexity needs to be considered when attempting to rationalize the differences in solubility between the investigated solvents, and the uniformly positive activity coefficients, which show that none of the evaluated solvents is capable of forming favourable interactions with the entire large, chemically diverse risperidone molecule. Notably, the two solvents with the highest mole fraction solubility represent antipodes on a polarity scale. While toluene, almost the least polar solvent evaluated, should be capable of adequate solvation of the hydrophobic and aromatic parts of the solute molecule, methanol, on the other hand, the most polar solvent investigated, should be capable of forming electrostatic interaction with the polar parts of the risperidone molecule, primarily through hydrogen bond donation. In order to further investigate the effect of nonpolar interactions, the solubility in n-hexane was measured at 303.15 K. The resulting value is very low, 0.44 g per kg solvent, corresponding to a mole fraction of 0.000092; an order of magnitude below the value in 2-propanol. The dramatic decrease in solubility between the apolar aromatic toluene, via cumene with a considerable aliphatic component, to the purely aliphatic hexane, points to the importance of the aromatic ring in forming interactions with the risperidone molecule. The possibility to extrapolate solubility data outside the experimental interval with sufficient confidence has important potential applications, e.g. for estimating transition temperatures for enantiotropic polymorphs, or for estimation of melting properties. Such extrapolations are frequently done on the basis of assuming linear van't Hoff plots [13] [14] [15] [16] . It has been shown [11] that a linear model will generally lead to poor accuracy, but with a proper choice of model extrapolation of van't Hoff curves to ln xeq = 0 can produce a reasonable estimate of the melting properties of the pure solute. At ln xeq = 0 the intersection of the extrapolated van't Hoff curve with the x-axis (Fig. 7) yields an estimate of the melting temperature. The inclination of a van't Hoff curve at a given temperature gives the van't Hoff enthalpy of solution, Eq. (8) , which at Tm is equal to the enthalpy of melting.
For risperidone form I, extrapolation of solubility data using a linear equation in T -1 results in unanimously overestimated values of the melting temperatures, by 119 K on average. This is as expected, given the non-linear shapes of the curves in the van't Hoff plot, Fig. 7 , and in agreement with results reported for other pharmaceutical molecules in organic solvents [11] . Extrapolation of the second-order polynomial given by Eq. (2) using the parameters in Table  5 leads to melting temperatures ranging from 397.7 K to 507.6 K, with an average over all 9 solvents of 426.5 K, which is an underestimation by 16 K compared to the experimental value (442.4 K). Data in acetone and ethyl acetate result in reasonably accurate estimates of Tm, with errors of 5.4 K and 7.6 K, respectively. Data in all alcohols lead to large underestimations of Tm, whereas extrapolation of cumene data results in a large overestimation. As regards the melting enthalpy, extrapolation of Eq. (2) in all solvents, with the exception of cumene, result in clear overestimations of the melting enthalpy, by on average 26.3 kJ mol -1 , compared to the experimental value (43.9 kJ mol -1 ). It is clear that data covering a wider temperature range, as well as a better functional form for the solubility temperature dependence, which distinguishes the contributions to solubility from the solid state activity from that of the activity coefficient at equilibrium, is needed for accurate and consistent extrapolations.
Conclusions
The melting point of risperidone form I is determined to be 442.4 K, and the associated enthalpy of fusion is 43.9 kJ mol -1 . The heat capacity of form I increases linearly from 471 to 647 J K -1 mol -1 over the temperature interval 270-410 K, and the heat capacity of the pure melt increases linearly from 839 to 857 J K -1 mol -1 over the interval 430-453 K. The extrapolated heat capacity difference between the melt and the solid amounts to 158.1 J K -1 mol -1 at the melting point and this difference is shown to increase linearly with decreasing temperature. The Gibbs energy of fusion and its enthalpic and entropic components is determined by extrapolation of calorimetric data from the melting point, and ΔfusG is estimated to be 9.4 kJ mol -1 at 298 K, with ΔfusH at 298 K estimated to have decreased to 15.7 kJ mol -1 from the value at the melting point.
The mole fraction solubility of risperidone at ambient temperature decreases in the order: toluene > methanol > 1-butanol > 1-propanol > cumene > ethyl acetate > ethanol > acetone > 2-propanol. Solutions of risperidone in all evaluated solvents show positive deviation from Raoult's law, with activity coefficients at 278 K in the range 4-42, decreasing monotonically towards unity at the melting point. It is shown that the majority of solubility curves exhibit non-linear behaviour in a van't Hoff graph, but are well approximated by second order polynomials in T -1 .
